CELL BIOTECH INTERNATIONAL A/S

CVR 34207283 · Public limited company (A/S) · Active · Low risk

CELL BIOTECH INTERNATIONAL A/S is a Public limited company (A/S), founded on , based in Kongens Lyngby. The company is registered in the industry agenturhandel med specialiseret varesortiment, bortset fra køretøjer. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.3 times the average for Danish companies. 14 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 26.1m and a net result of DKK 2.1m. CEO: Chung Myung Jun.

Bankruptcy risk for CELL BIOTECH INTERNATIONAL A/S

0.5%
probability of bankruptcy within 12 months
Low risk

0.3 × the average (1.41%) · higher risk than 58% of active Danish companies

Lowest riskHighest risk

Increases the risk

Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO changes1 · bankruptcy rate 11.4%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
34207283
Status
Active
Company type
Public limited company (A/S)
Founded
(14 years)
Address
Sorgenfrivej 15
2800 Kongens Lyngby
Municipality
Lyngby-Taarbæk
Industry
Agenturhandel med specialiseret varesortiment, bortset fra køretøjer (461890)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 10.0m
Employees
8 (2018)
Auditor
PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 14
Missing annual reportNo
Negative equityNo
Equity ratio44.3%
Current ratio136%
Moves (last 2 years)1
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address9
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 8.7mDKK 7.0m
Net profitDKK 2.1mDKK 1.4m
EquityDKK 26.1mDKK 16.0m
Total assetsDKK 58.9mDKK 27.4m
CashDKK 26.0m–
Short-term debtDKK 32.8m–
Tax owedDKK 97k–
Avg. employees7–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisions­aktie­selskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202585
1 Jan 2024 – 31 Dec 202486
1 Jan 2023 – 31 Dec 202359
1 Jan 2022 – 31 Dec 202275
1 Jan 2021 – 31 Dec 2021110
1 Jan 2020 – 31 Dec 202081
1 Jan 2019 – 31 Dec 201998
1 Jan 2018 – 31 Dec 2018128
1 Jan 2017 – 31 Dec 201787
1 Jan 2016 – 31 Dec 2016111
1 Jan 2015 – 31 Dec 201582
1 Jan 2014 – 31 Dec 201468
1 Jan 2013 – 31 Dec 201392
1 Jan 2012 – 31 Dec 201270

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChung Myung JunCurrent
CEOPeter Andreas Stakemann
BoardChung Myung JunCurrent
BoardYun Young OakCurrent
BoardChung Yu SookCurrent
BoardPeter Andreas Stakemann
BoardThomas Jeffrey Malherbes Gullacksen
BoardUlf Lund
BoardYoung Oak Yun
BoardYoon Seong Bae
Owner (100%)Cell Biotech Co. Ltd.Current
AuditorPKF Munkebo Eriksen Funch, Statsautoriseret RevisionsaktieselskabCurrent
AuditorEY Godkendt Revisionspartnerselskab
FounderApS KBUS 38 nr.3117Current

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Address history (5 moves)

Sorgenfrivej 15, 2800 Kongens Lyngby
Strandvejen 125, 2900 Hellerup
Strandvejen 100, 1., 2900 Hellerup
c/o Symbion Science Park, Fruebjergvej 3, 2100 København Ø
c/o Nyborg & Rørdam Advokatfirma, Store Kongensgade 77, 1264 København K
Kronprinsessegade 18, 1306 København K

Former names

CELL BIOTECH INTERNATIONAL A/S – now
A/S PAS 2012 NR. 1007 –

Employees per year

Number of employees at CELL BIOTECH INTERNATIONAL A/S per year5102012: 320122013: 620132014: 620142015: 720152016: 920162017: 1020172018: 82018

Other companies at the same address

Similar companies in Lyngby-Taarbæk

Questions and answers about CELL BIOTECH INTERNATIONAL A/S

Has CELL BIOTECH INTERNATIONAL A/S gone bankrupt?

No, CELL BIOTECH INTERNATIONAL A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of CELL BIOTECH INTERNATIONAL A/S?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.

Who is the CEO of CELL BIOTECH INTERNATIONAL A/S?

Chung Myung Jun is the CEO of CELL BIOTECH INTERNATIONAL A/S.

Who is the auditor of CELL BIOTECH INTERNATIONAL A/S?

CELL BIOTECH INTERNATIONAL A/S most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.

When was CELL BIOTECH INTERNATIONAL A/S founded?

CELL BIOTECH INTERNATIONAL A/S was founded on 1 January 2012.

What is the equity of CELL BIOTECH INTERNATIONAL A/S?

Equity was DKK 26.1m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.